
Investing in healthcare companies, such as McKesson Corporation (MCK), is a smart move in the face of high inflation and other macroeconomic woes due to inelastic demand for their products and services. MCK has defied the bear market over the past year, supported by its solid fundamentals.
In terms of non-GAAP Price/Earnings (PE), the stock is currently trading at 14.14x, 28.5% lower than the industry average of 19.77x. The company’s 1.12x non-GAAP Price/Earnings-to-Growth PEG is 46.8% lower than the industry average of 2.11x. The stock trading at a discount to its peers could be a wise investment now.